|
|
Flaxseed |
|
Flaxseed (English) Linum usitatissimum
(Botanical) Linaceae (Plant Family) Lini semen
(Pharmacopeial)
|
|
| |
|
Overview |
|
Used by the ancient Egyptians, flax was originally grown in the Mediterranean
and Western Europe for industrial, nutritional, and medicinal uses. It is now
found as both a cultivated and semi-wild plant throughout temperate and tropical
regions.
Flax is a rich source of dietary fiber that can lower cholesterol levels. The
oil in flaxseed (linseed) is medicinally important for cardiovascular conditions
and cancer prevention. Linseed oil contains both omega-3 fatty acids and omega-6
fatty acids as well as plant nutrients such as phytoestrogens. Linoleic and
alpha-linolenic acid are essential fatty acids that the body requires for normal
cellular function.
Alpha-linolenic acid (ALA) is an omega-3 oil while linoleic acid is an
omega-6 oil. Flaxseed oil is nature's richest storehouse of omega-3 fatty acids.
The content of omega-3 oils in flaxseed is more than double the quantity in fish
oils. Experts think that the high amount of unsaturated fatty acids in flaxseed
oil significantly reduces the risk for atherosclerosis. |

|
|
Macro Description |
|
Flax is an annual plant that grows up to five feet in height. It flourishes
in deep moist soils rich in sand, silt, and clay. Ideally, flax should be
quickly grown and harvested. Its gray-green leaves and delicate cordial blue (or
sometimes white) flowers make it easily recognizable. The plant flowers only in
the morning. The spherical, pea-size fruit contain flat, shiny, brown seeds
filled with linseed oil. Mucilage is obtained from the husks of the seeds. Both
the oil and mucilage of linseed are used for a variety of health conditions. The
fruits are threshed to loosen the seeds, and the seeds do not actually ripen
until after the plant has been harvested. |

|
|
Part Used/Pharmaceutical
Designations |
|
- Flowers (fresh flowering plant)
- Seeds (flaxseed oil)
|

|
|
Constituents/Composition |
|
Mucilages (3% to 10%); cyanogenic glycosides 0.05% to 0.1% (linustatin and
neolinustin); fatty oil (30% to 45%), includes linolenic acid (40% to 70%),
linoleic acid (10% to 25%), oleic acid (13% to 30%); mono- and triglycerides,
free sterols, sterol esters, hydrocarbons: proteins (25%), ballast (25%),
lignans, phenylpropane derivatives. |

|
|
Commercial
Preparations |
|
Flaxseed is available as whole, bruised, or milled seeds. Linseed oil can be
purchased in liquid form (to use in preparing food) or as soft gels for dietary
supplementation. For optimal benefits, flaxseed oil should be added to foods
(such as salad dressings) but not cooked or heated. |

|
|
Medicinal
Uses/Indications |
|
Traditional Actions: whole seed, crushed seed, seed oil: bulking laxative,
anti-inflammatory, demulcent, antitussive, emollient, vulnerary and expectorant.
Was also historically used for gonorrhea, dysentary, and diarrhea, although
herbalists no longer use it for these conditions.
Internal conditions: whole or cracked seed preparations for chronic
constipation, colon problems due to laxative abuse, irritable colon,
diverticulitis, mucilage for gastritis and enteritis. Decoction used for cough
and bronchial irritation, bladder or urinary tract inflammation.
External conditions: poultice for burns and scalds, local skin irritation,
drawing poultices for local infections, pimples, boils, etc.
Clinical applications: elevated cholesterol and triglycerides; preventative
for cardiovascular disease and cancer |

|
|
Pharmacology |
|
Epidemiological studies suggest that omega-3 oils significantly reduce the
risk of heart disease. Omega-3 fatty acids lower LDL cholesterol and
triglyceride levels. They also block platelet over-aggregation, reduce blood
pressure in persons with hypertension, and lower fibrinogen levels.
Consequently, omega-3 oils are clinically beneficial for hypercholesterolemia,
angina, hypertension, psoriasis, eczema, cancer, and autoimmune disorders such
as rheumatoid arthritis and multiple sclerosis.
ALA, the main fatty acid in linseed, improves arterial function by increasing
the strength, flexibility, and permeability of cell membranes. ALA offers
greater protection against heart attacks than oleic acid (found in canola and
olive oil). But in one study, ALA was not responsible for the
anti-arteriosclerosis effect in Type II flaxseed. ALA comprises only 2% to 3% of
the total oil in Type II flaxseed.
Linolenic acid is a biologic precursor of prostaglandins. Prostaglandins are
hormone-like substances that influence serum cholesterol levels, red blood cell
aggregation, and smooth muscle function. Omega-3 oils help prevent cancer,
stroke, and heart attacks by mediating the actions of prostaglandins. In other
research, linseed oil had antibacterial action. Both linolenic acid and
hydrolyzed linseed oil blocked the growth of methicillin-resistant strains of
Staphylococcus aureus.
Flaxseed is a rich source of lignans. Lignans are platelet-activating
factor-receptor antagonists that have recently sparked medical interest because
of their role in improving cardiovascular health. The lignans in linseed oil
have both estrogenic and anti-estrogenic effects. Phytoestrogens in linseed are
thought to favorably reduce certain symptoms of menopause while other lignans
act as weak estrogen antagonists.
There is new evidence that anti-estrogenic activity as well as other
mechanisms inhibit carcinogenesis at various stages of tumor development. ALA
and other compounds in linseed oil are known to have anti-cancer activity,
particularly during the initiation and promotional stages of carcinogenesis.
Lignans also suppress colon tumor growth, and it appears that flaxseed has both
short-term and long-term protective effects against colon cancer.
In one investigation, the lignans enterolactone and enterodiol reduced the
number of tumors observed in test animals genetically prone to developing
mammary tumors. In another study, mice with experimentally-induced melanoma had
flaxseed added to their diets. Flaxseed reduced metastasis and suppressed the
development of metastatic secondary tumors in the animals. These findings
strongly support the use of flaxseed as a complementary nutritional therapy for
preventing metastasis in cancer patients. However, it should be noted that the
correlations between dietary flaxseed supplements and cancer inhibition at
various stages of carcinogenesis have been inconsistent. |

|
|
Dosage Ranges and Duration of
Administration |
|
Recommended dosage:
- Flaxseed: 1 tbsp. whole or bruised (but not ground) seed with 150 ml
liquid bid to tid times a day for gastritis and enteritis; 2 to 3 tbsp. bulk
seeds taken with 10 times the amount of water as a bulk laxative
- Poultice: 100 g soaked in boiling water for 10 to 15 minutes,
strained, placed in cheesecloth and applied
- Decoction: 15 g of whole seed simmered in 1 cup water for 10 to 15
minutes
- Flaxseed oil: 1 tbsp. daily
|

|
|
Side
Effects/Toxicology |
|
There are no side effects if flaxseed and linseed oil are taken within
recommended therapeutic doses. However, large quantities of flaxseed consumed
without sufficient fluid can cause ileus (constriction of the small
intestine). |

|
|
Warnings/Contraindications/Precautions |
|
Contraindications include esophageal stricture, ileus, GI stricture, and
acute intestinal inflammation. No contraindications for pregnant or lactating
women. |

|
|
Interactions |
|
No clinically significant interactions between flaxseed and conventional
medications are known to have been reported in the literature to date, including
the German Commission E monograph (Blumenthal 1998). Although clinical relevance
is unknown, flaxseed may interfere with the absorption of certain medications;
therefore, ingestion of flaxseed several hours before or after other herbs or
medications may be warranted. Please see monograph on ALA for additional
information regarding that active ingredient. |

|
|
Regulatory and Compendial
Status |
|
The U.S. FDA classifies flaxseed as a dietary
supplement. |

|
|
References |
|
Allman MA, Pena MM, Pang D. Supplementation with flaxseed oil versus
sunflowerseed oil in healthy young men consuming a low fat diet: effects on
platelet composition and function. Eur J Clin Nutr. 1995;49:169-178.
Bierenbaum ML, Reichstein R, Watkins TR. Reducing atherogenic risk in
hyperlipemic humans with flax seed supplementation: a preliminary report. J
Am Coll Nutr. 1993;12:501-504.
Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic
Guide to Herbal Medicines. Boston, Mass: Integrative Medicine
Communications; 1998:47, 132.
British Herbal Pharmacopoeia. 4th ed. Dorset, England: British Herbal
Medicine Association; 1996.
Clark WF, et al. Flaxseed: a potential treatment of lupus nephritis.
Kidney Int. 1995;48:475-480.
Cunnane SC, et al. High alpha-linolenic acid flaxseed (Linum
usitatissimum): some nutritional properties in humans. Br J Nutr.
1993;69:443-453.
Cunnane SC. Nutritional attributes of traditional flaxseed in healthy-young
adults. Am J Clin Nutr. 1995;61:62-68.
De Smet P, Keller K, Hänsel R, Chandler R, eds. Adverse Effects of Herbal
Drugs. New York, NY: Springer-Verlag; 1997.
Grieve M. A Modern Herbal. New York, NY: Dover Publications;
1971:1:309-310.
Gruenwald J, Brendler T, Jaenicke C, et al., eds. PDR for Herbal
Medicines. Montvale, NJ: Medical Economics Co; 1998:940-941.
Prasad K, Mantha S, Muir A, Westcott N. Reduction of hypercholesterolemic
arteriosclerosis by CDC-flaxseed with very low alpha-linolenic acid.
Arteriosclerosis. 1998;434:367-375.
Serraino M, Thompson L. The effect of flaxseed supplementation on the
initiation and promotional stages of mammary tumorigenesis. Nutr Cancer.
1992;25:153-159.
Sung M, Lautens M, Thompson L. Mammalian lignans inhibit the growth of
estrogen-independent human colon tumor cells. Anticancer Research.
1998;1346:1405-1408.
Thompson L, Richard S, Orcheson L, Seidl M. Flaxseed and its lignan and oil
components reduce mammary tumor growth at a late stage of carcinogenesis.
Carcinogenesis. 1996;434:1373-1376.
Yan L, Yee J, Li D, McGuire M, Thompson L. Dietary flaxseed supplementation
and experimental metastasis of melanoma cells in mice. Cancer Lett.
1998;61:181-186. |

|
Copyright © 2000 Integrative Medicine
Communications This publication contains
information relating to general principles
of medical care that should not in any event be construed as specific
instructions for individual patients. The publisher does not accept any
responsibility for the accuracy of the information or the consequences arising
from the application, use, or misuse of any of the information contained herein,
including any injury and/or damage to any person or property as a matter of
product liability, negligence, or otherwise. No warranty, expressed or implied,
is made in regard to the contents of this material. No claims or endorsements
are made for any drugs or compounds currently marketed or in investigative use.
The reader is advised to check product information (including package inserts)
for changes and new information regarding dosage, precautions, warnings,
interactions, and contraindications before administering any drug, herb, or
supplement discussed herein. | |